Eva Ulla Lorentzen (Eva Lorentzen, Eva U Lorentzen)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Angiotensin Converting Enzyme

Top Venues

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Richard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn, Tobias Max Nowacki, Jörn Arne Meier, Jonel Trebicka, Phil-Robin Tepasse
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects. Vaccines 11 (9) (2023)
Michael Schöfbänker, Rieke Neddermeyer, Theresa Guenther, Marlin M Mueller, Marie-Luise Romberg, Nica Classen, Marc T Hennies, Eike R Hrincius, Stephan Ludwig, Joachim E Kuehn, Eva Ulla Lorentzen
Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Vaccines 11 (12) (2023)
Michael Schöfbänker, Rieke Neddermeyer, Theresa Guenther, Marlin M Mueller, Marie-Luise Romberg, Nica Classen, Marc T Hennies, Eike R Hrincius, Stephan Ludwig, Joachim E Kuehn, Eva Ulla Lorentzen
Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Vaccines 11 (12) (2023)
Nica Classen, Diana Ulrich, Arne Hofemeier, Marc Tim Hennies, Wali Hafezi, Aleksandra Pettke, Marie-Luise Romberg, Eva Ulla Lorentzen, Andreas Hensel, Joachim E Kühn
Broadly Applicable, Virus-Free Dual Reporter Assay to Identify Compounds Interfering with Membrane Fusion: Performance for HSV-1 and SARS-CoV-2. Viruses 14 (7) (2022)
Richard Vollenberg, Phil-Robin Tepasse, Joachim Ewald Kühn, Marc Hennies, Markus Strauss, Florian Rennebaum, Tina Schomacher, Göran Boeckel, Eva Ulla Lorentzen, Arne Bokemeyer, Tobias Max Nowacki
Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2. Biomedicines 10 (1) (2022)
Richard Vollenberg, Phil-Robin Tepasse, Eva Ulla Lorentzen, Tobias Max Nowacki
Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study. Journal of personalized medicine 12 (5) (2022)